Skip to main content

Table 2 Death and adverse clinical event in studies

From: Clinical effects of cyclosporine A on reperfusion injury in myocardial infarction: a meta-analysis of randomized controlled trials

Study-time

Death or adverse clinical event

Event CsA group event\total

Control group event\total

Piot 2008-2 days

Heart failure

2\30

7\28

Piot 2008-3 months

Heart failure

1\30

3\28

Ghaffari 2012-6 months

Death

9\50

10\51

Ghaffari 2012-7 days

Death

4\50

6\51

Ghaffari 2013-2 days

Major arrhythmia

9\50

12\51

Ghaffari 2013-2 days

Heart failure

18\50

19\51

Cung 2015-12 months

Death

28\475

26\485

Cung 2015-12 months

Heart failure

90\395

90\396

Cung 2015-12 months

Left ventricular remodeling

169\395

161\396

Cung 2015-12 months

Cardiogenic shock

26\395

14\396

Cung 2015-12 months

Recurrent myocardial infarction

9\395

15\396

Cung 2015-12 months

Stroke

7\395

12\396

Cung 2015-12 months

Major bleeding

7\395

9\396

Ottani 2016-6 months

Death

12\207

6\203

Ottani 2016-6 months

Heart failure

21\207

23\203

Ottani 2016-6 months

Cardiogenic shock

6\207

3\203

Ottani 2016-6 months

Re-hospitalization

28\207

30\203